1. Home
  2. VERV vs MSBI Comparison

VERV vs MSBI Comparison

Compare VERV & MSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • MSBI
  • Stock Information
  • Founded
  • VERV 2018
  • MSBI 1881
  • Country
  • VERV United States
  • MSBI United States
  • Employees
  • VERV N/A
  • MSBI N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • MSBI Major Banks
  • Sector
  • VERV Health Care
  • MSBI Finance
  • Exchange
  • VERV Nasdaq
  • MSBI Nasdaq
  • Market Cap
  • VERV 475.0M
  • MSBI 511.1M
  • IPO Year
  • VERV 2021
  • MSBI 2016
  • Fundamental
  • Price
  • VERV $6.14
  • MSBI $24.61
  • Analyst Decision
  • VERV Strong Buy
  • MSBI Hold
  • Analyst Count
  • VERV 4
  • MSBI 4
  • Target Price
  • VERV $25.75
  • MSBI $27.75
  • AVG Volume (30 Days)
  • VERV 1.5M
  • MSBI 76.4K
  • Earning Date
  • VERV 02-25-2025
  • MSBI 01-23-2025
  • Dividend Yield
  • VERV N/A
  • MSBI 5.04%
  • EPS Growth
  • VERV N/A
  • MSBI N/A
  • EPS
  • VERV N/A
  • MSBI 2.30
  • Revenue
  • VERV $24,396,000.00
  • MSBI $259,944,000.00
  • Revenue This Year
  • VERV $97.47
  • MSBI N/A
  • Revenue Next Year
  • VERV N/A
  • MSBI $0.14
  • P/E Ratio
  • VERV N/A
  • MSBI $10.69
  • Revenue Growth
  • VERV 219.91
  • MSBI N/A
  • 52 Week Low
  • VERV $4.31
  • MSBI $20.54
  • 52 Week High
  • VERV $19.34
  • MSBI $28.10
  • Technical
  • Relative Strength Index (RSI)
  • VERV 53.75
  • MSBI 50.84
  • Support Level
  • VERV $5.32
  • MSBI $23.86
  • Resistance Level
  • VERV $6.87
  • MSBI $25.76
  • Average True Range (ATR)
  • VERV 0.52
  • MSBI 0.77
  • MACD
  • VERV -0.00
  • MSBI 0.13
  • Stochastic Oscillator
  • VERV 56.74
  • MSBI 66.86

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.

Share on Social Networks: